clinical trials

Pharmalot By Ed Silverman

FDA threatens to fine another drug maker for failing to report clinical trial results

Pharmalot By Ed Silverman

Most clinical trials failed to meet U.S. transparency requirements for recently approved drugs

Health Tech By Katie Palmer

‘Some very noble, some less than noble’: The growing health data marketplace sparks privacy concerns

Pharmalot By Ed Silverman

In a tentative sign of transparency, more leading U.S. universities are reporting clinical trial results

Pharmalot By Ed Silverman

In Belgium, too many clinical trial sponsors waffle about reporting required results

Pharmalot By Ed Silverman

For the first time, the FDA may fine a drug maker for failing to post clinical trial results

Biotech By Anissa Gardizy — Boston Globe

Thermo Fisher buys contract-research company PPD for $17.4 billion

Health By Andrew Joseph

Huntington’s community grieves not just one therapeutic setback, but two

Pharmalot By Ed Silverman

Clinical study reports hold more details about the side effects of cancer drugs

Health Tech By Katie Palmer

How artificial intelligence could make clinical trials smarter

Health Tech By Erin Brodwin and Mario Aguilar

Two ways Fitbit could boost Google’s health ambitions

Health Tech By Casey Ross

‘The trend is irreversible’: How Covid-19 could drive a shift toward decentralized trials

Health By Priyanka Runwal

Cancer clinical trial enrollment has plummeted. Will patients come back amid Covid-19?

First Opinion By Andrea Bastek

The pandemic is accelerating transformation agendas in the clinical research industry

Health Tech By Casey Ross

Drug companies deliver a vote of confidence in adaptive trial for Covid-19

Pharma By Rebecca Ritzel

FDA pushes drug companies to include younger people in breast cancer drug trials 

Biotech By Kate Sheridan

Seres announces positive late-stage results for its microbe-based drug

First Opinion By Joseph S. Ross, Joanne Waldstreicher and Harlan M. Krumholz

Sharing clinical trial data: lessons from the YODA Project

First Opinion By Jen Goldsack, Rachel A. Chasse and William A. Wood

Digital endpoints library can aid clinical trials for new medicines

Pharmalot By Ed Silverman

Flawed trials supported half of recent approvals of cancer drugs in Europe, study says

First Opinion By Bobby Clark and Ronnie Tepp

Community engagement is key to clinical trial recruitment and diversity

First Opinion By Rebecca Li

Move clinical trial data sharing from an option to an imperative

First Opinion By Louise Aronson

A new NIH rule won’t be enough to make clinical research more inclusive

First Opinion By Nancy A. Dreyer

Real-world evidence is changing the way we study drug safety and effectiveness

First Opinion By Jane L. Delgado and Edward Abrahams

Diversity in clinical trials defines good science and better medicine